What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study

International Journal of Gynecological Cancer

Volumn 16, Issue 4, 2006, Pages 1569-1573

  Lee, K Bm ^a   Lee, J M ^b   Park, C Y ^a   Lee, K B ^a   Cho, H Y ^a   Ha, S Y ^a  

^a Gachon University College of Medicine   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Squamous cell carcinoma; Stage IB1

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPH VESSEL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERUS CANCER;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STROMAL CELLS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 33745936417     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00628.x     Document Type: Article

References (28)

1. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002;41:185-207.
2. Harrison TA, Sevin BU, Koechli O et al. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Gynecol Oncol 1993;50:310-5.
3. Anton-Culver H, Bloss JD, Bringman D, Lee-Feldstein A, DiSaia P, Manetta A. Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: a population-based epidemiologic study. Am J Obstet Gynecol 1992;166:1507-14.
4. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
5. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001;357:1490-3.
6. Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001;164:1151-2.
7. Gershenson DM, McGuire WP, Gore M, Quinn MA, Thomas G. Adenocarcinoma of the cervix. In: Hopkins MP, Smith HO, ed. Gynecologic cancer: controversies in management, 1st edn. Philadelphia: Churchill Livingstone, 2004:149-60.
8. Grigsby PW, Perez CA, Kuske RR et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol 1988;12:289-96.
9. Kilgore LC, Soong SJ, Gore H, Shingleton HM, Hatch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988;31:137-53.
10. Shingleton HM, Bell MC, Fremgen A et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76:1948-55.
11. Ayhan A, Al RA, Baykal C, Demirtas E, Yuce K, Ayhan A. A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer 2004;14:279-85.
12. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol 2000;79:289-93.
13. Hopkins MP, Schmidt RW, Roberts JA, Morley GW. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 1988;72:915-21.
14. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
15. Look KY, Brunetto VL, Clarke-Pearson DL et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1996;63:304-11.
16. Tavassoli FA, Hoefler H, Holland R et al. Tumours of uterine cervix. In Tavassoli FA, Devilee P, eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon, France: IARC Press, 2003.
17. Hacker NF. Cervical Cancer. In Berek JS, Hacker NF, eds. Practical gynecologic oncology, 4th edn. Philadelphia: Lippincott Willimans & Wilkins, 2005:365.
18. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
19. West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys 1995;31:841-6.
20. Costa MJ, McIlnay KR, Trelford J. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol 1995;26:829-37.
21. McLellan R, Dillon MB, Woodruff JD, Heatley GJ, Fields AL, Rosenshein NB. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol 1994;52:253-9.
22. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT. Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
23. Berek JS, Hacker NF, Fu YS, Sokale JR, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-52.
24. Zaino RJ, Ward S, Delgado G et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Cancer 1992;69:1750-8.
25. Matthews CM, Burke TW, Tornos C et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol 1993;49:19-23.
26. Smith HO, Qualls CR, Romero AA et al. Is there a difference in survival for IA1 and IA2 adenocarcinoma of the uterine cervix? Gynecol Oncol 2002;85:229-41.
27. Cohn DE, Peters WA III, Muntz HG et al. Adenocarcinoma of the uterine cervix metastatic to lymph nodes. Am J Obstet Gynecol 1998;178:1131-7.
28. Irie T, Kigawa J, Minagawa Y et al. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol 2000;26:464-7.